KR100967018B1 - Cosmetic composition comprising a herbal extration - Google Patents

Cosmetic composition comprising a herbal extration Download PDF

Info

Publication number
KR100967018B1
KR100967018B1 KR1020030022179A KR20030022179A KR100967018B1 KR 100967018 B1 KR100967018 B1 KR 100967018B1 KR 1020030022179 A KR1020030022179 A KR 1020030022179A KR 20030022179 A KR20030022179 A KR 20030022179A KR 100967018 B1 KR100967018 B1 KR 100967018B1
Authority
KR
South Korea
Prior art keywords
extract
skin
present
whitening
leaves
Prior art date
Application number
KR1020030022179A
Other languages
Korean (ko)
Other versions
KR20040087777A (en
Inventor
공우식
강응수
김관철
임동진
Original Assignee
애경산업(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애경산업(주) filed Critical 애경산업(주)
Priority to KR1020030022179A priority Critical patent/KR100967018B1/en
Publication of KR20040087777A publication Critical patent/KR20040087777A/en
Application granted granted Critical
Publication of KR100967018B1 publication Critical patent/KR100967018B1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B23MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23CMILLING
    • B23C5/00Milling-cutters
    • B23C5/006Details of the milling cutter body
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B23MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23CMILLING
    • B23C3/00Milling particular work; Special milling operations; Machines therefor
    • B23C3/12Trimming or finishing edges, e.g. deburring welded corners
    • B23C3/122Trimming or finishing edges, e.g. deburring welded corners of pipes or cylinders
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B23MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23CMILLING
    • B23C5/00Milling-cutters
    • B23C5/02Milling-cutters characterised by the shape of the cutter
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B23MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23CMILLING
    • B23C5/00Milling-cutters
    • B23C5/16Milling-cutters characterised by physical features other than shape
    • B23C5/20Milling-cutters characterised by physical features other than shape with removable cutter bits or teeth or cutting inserts

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 피부에 안전하고 티로시나제 활성을 억제하여 멜라닌 생성억제효과를 갖는 식물 추출물을 함유한 피부 미백 화장료에 관한 것으로, 본 발명의 식물 추출물을 함유한 화장료는 통상의 화장료 조성에 맬로우(Malva Sylvestris), 서양앵초(Primula Veris), 성모초(Alchemilla Vulgaris), 꼬리풀, 야로우(Achillea Millefolium) 식물의 꽃과 잎에서 추출한 추출물 및 박하(Menthe Herba), 메릿사(Melissa officinalis) 잎에서 추출한 추출물물 및 효모추출물이 일정 비율로 혼합되어 조성됨을 특징으로 한다.The present invention relates to a skin whitening cosmetic containing a plant extract that is safe for the skin and inhibits tyrosinase activity and has an effect of inhibiting melanin production. The cosmetic containing the plant extract of the present invention is a mallow ( Malva Sylvestris) in a conventional cosmetic composition. ), Extracts from flowers and leaves of Primula Veris , Alchemilla Vulgaris , tail grass , Achillea Millefolium plants, and extracts from leaves of Menthe Herba and Melissa officinalis Yeast extract is characterized in that the composition is mixed at a certain ratio.

상술한 바와 같이 본 발명의 추출물은 함유하는 화장료는 추출물의 각 구성성분이 천연추출물과 미생물 발효물로 피부안전성이 높고, 제품의 안정성에 영향을 미치지 않는 농도에서 피부색개선 효과가 있고 색소침착을 감소시키는 효과가 있어 피부개선 및 미백화장료에 유효농도로 사용할 수 있다. .As described above, the extract of the present invention is a cosmetic containing each component of the extract is a natural extract and microbial fermentation high skin safety, has a skin color improvement effect at a concentration that does not affect the stability of the product and reduces pigmentation It can be used at effective concentration in skin improvement and whitening cosmetics. .

티로시나제, 미백작용Tyrosinase, whitening

Description

식물 추출물을 함유한 피부 미백 화장료{Cosmetic composition comprising a herbal extration}Skin whitening cosmetics containing plant extracts {Cosmetic composition comprising a herbal extration}

본 발명은 식물 추출물을 함유한 피부 미백 화장료에 관한 것으로, 보다 자세하게는 피부에 안전하고 티로시나제 활성을 억제하여 멜라닌 생성억제효과를 갖는 식물 추출물을 함유한 피부 미백 화장료에 관한 것이다.The present invention relates to a skin whitening cosmetic containing a plant extract, and more particularly, to a skin whitening cosmetic containing a plant extract having a melanin production inhibitory effect by being safe for the skin and inhibiting tyrosinase activity.

자외선에 의한 멜라닌 색소의 생성은 피부색소 침착의 주된 원인이 되고 있으며, 이러한, 멜라닌 색소는 티로시나제 효소에 의해 만들어지는 페놀계 고분자물질이며, 티로시나제는 다양한 생물체에 고르게 분포하는 자외선에 의한 피부손상을 보호해 주는 피부보호기작을 한다. 따라서 멜라닌 생성 및 색소침착의 주원인인 티로시나제의 활성저해는 피부 미백 연구에 있어서 중요한 사항으로 되어왔다.The production of melanin pigment by ultraviolet rays is a major cause of skin pigmentation, and this melanin pigment is a phenolic polymer made by tyrosinase enzyme, and tyrosinase protects skin damage caused by UV rays evenly distributed to various organisms. Do the skin protection mechanism. Therefore, inhibition of tyrosinase, a major cause of melanogenesis and pigmentation, has become an important issue in the study of skin whitening.

현재까지 개발된 티로시나제 저해제에는 아스코르브산, 코진산, 하이드로퀴논 및 과산화수소, 과산화아연, 과산화마그네슘과 같은 과산화물등이 있으나 이러한 물질들은 안정성 및 안전성이 충분하지 못한 경우가 대부분 이었다. 최근에는 미백효과가 상기 물질보다는 적지만 안정성 및 안전성을 개선시킨 많은 유도체 및 식물성 미백제들이 공지되고 있는 실정이다. 이러한 식물성 미백제들은 일본 특개 소 53-3538호에 개시된 효모산 및 효모산 유도체와 대한민국 특허등록 228741호에 개시된 오미자와 같은 천연물이 그 대표적인 예라고 할 수 있다. 그러나, 상기 물질의 경우에도 티로시나제의 저해 활성이 미약하다는 단점이 있다.Tyrosinase inhibitors developed to date include ascorbic acid, kojic acid, hydroquinone and peroxides such as hydrogen peroxide, zinc peroxide, and magnesium peroxide. However, these substances were often insufficient in stability and safety. Recently, many derivatives and vegetable whitening agents have been known which have a smaller whitening effect than the above materials but have improved stability and safety. Such vegetable whitening agents are representative examples of yeast acid and yeast acid derivatives disclosed in Japanese Patent Application Laid-Open No. 53-3538, and natural products such as Schizandrae disclosed in Korean Patent Registration No. 228741. However, even in the case of the substance has a disadvantage that the inhibitory activity of tyrosinase is weak.

본 발명자들은 미백에 도움을 줄 수 있는 다양한 식물로 부터 활성 성분을 추출하고 여기에, 또한 미백에 효과가 있는 발효된 미생물을 일정하게 혼합함으로 하여 티로시나제의 저해 활성을 높일 수 있을 뿐 아니라, 안전성도 양호하게 유지할 수 있다는데 착안하여 본 발명을 완성하였다.The present inventors extract active ingredients from various plants that can help whitening, and also by constantly mixing fermented microorganisms effective in whitening, thereby increasing the inhibitory activity of tyrosinase, as well as safety. The present invention has been completed with the focus on maintaining good quality.

따라서, 본 발명의 목적은 상기한 티로시나제 억제 효능을 나타내는 다양한 식물로 부터 활성 성분을 추출하고 여기에, 또한 미백에 효과가 있는 발효된 미생물을 일정하게 혼합하여 티로시나제의 저해 활성이 높은 피부 미백 화장료를 제공하기 위한 것이다.Therefore, an object of the present invention is to extract the active ingredient from the various plants exhibiting the above-described tyrosinase inhibitory effect, and also to the skin whitening cosmetics having high inhibitory activity of tyrosinase by constantly mixing fermented microorganisms which are also effective in whitening. It is to provide.

더욱이 본 발명은 피부 미백에 대한 화장료로서의 유용한 효과를 나타내면서 기존 화장료의 안정성을 저해하지 않는 상기한 추출물을 함유한 화장료를 제공하기 위한 것이다.Furthermore, the present invention is to provide a cosmetic containing the above-mentioned extract that does not inhibit the stability of the existing cosmetics while showing a useful effect as a cosmetic on the skin whitening.

상기한 목적을 달성하기 위한 본 발명의 식물 추출물을 함유한 화장료는 통상의 화장료 조성에 맬로우(Malva Sylvestris), 서양앵초(Primula Veris), 성모초(Alchemilla Vulgaris), 꼬리풀, 야로우(Achillea Millefolium) 식물의 꽃과 잎에서 추출한 추출물 및 박하(Menthe Herba), 메릿사(Melissa officinalis) 잎에 서 추출한 추출물물 및 효모추출물이 일정 비율로 혼합되어 조성됨을 특징으로 한다.Cosmetics containing the plant extract of the present invention for achieving the above object is Malva Sylvestris , Primula Veris , Alchemilla Vulgaris , tail grass , Yarrow ( Achillea Millefolium ) in a conventional cosmetic composition Extracts and extracts from the leaves and peppermint ( Menthe Herba ), leaves of the plant ( Melissa officinalis ) and yeast extract of the plant is characterized in that the composition is mixed.

상기 각 구성성분은 일정 구성비율로 할 수 는있으나 바람직하기로는 동일 중량으로 한다.Each of the components may be in a certain ratio but preferably the same weight.

상기한 본 발명에 따른 추출물은 맬로우, 서양앵초, 성모초, 꼬리풀, 야로우 식물의 꽃과 잎 추출물 및 박하, 메릿사 잎 추출물은 이들 각각의 꽃 또는 잎을 각각 분쇄하여 분말로 형성하고 물 또는 유기용매를 각각 또는 혼합한 것을 용매로 하여 추출할 수 있다.The extract according to the present invention described above is mallow, primrose, virginia, tail grass, Yarrow plant flower and leaf extract and peppermint, Meredith leaf extract is formed by pulverizing each of these flowers or leaves to powder and water or The organic solvent can be extracted by using each or a mixture thereof as a solvent.

본 발명은 상기와 같이 얻은 추출물을 효모추출물과 통상적인 화장료에 일정 비율로 첨가 혼합하여 화장료를 얻음을 특징으로한다. The present invention is characterized in that the extract obtained as described above is added to and mixed with the yeast extract and a conventional cosmetic in a certain ratio to obtain a cosmetic.

상기 본 발명의 화장료 조성물에는 더욱 바람직하기로는 글리세린과 같은 저급 알코올에서 선택된 하나 또는 그 이상의 것이 일정 비율로 혼합되도록 한다.In the cosmetic composition of the present invention, more preferably, one or more selected from lower alcohols such as glycerin is mixed at a predetermined ratio.

본 발명의 또 다른 구성인 효모추출물은 배양액으로 부터 얻을 수있다.Yeast extract, another constitution of the present invention, can be obtained from a culture solution.

더욱이 본 발명에 따른 추출물을 함유하는 화장료의 제형으로는 유연 화장수(스킨), 로션, 에센스, 크림 등 통상의 화장료 제형에 부가되어 제조될 수 있다.Furthermore, the formulation of the cosmetic composition containing the extract according to the present invention can be prepared in addition to the usual cosmetic formulations such as skin lotion (skin), lotion, essence, cream.

본 발명에 따른 추출물은 첨부되는 화장료의 건조중량에 대하여 0.001∼50중량%, 바람직하게는 0.01∼5중량%의 함량으로 함유하게 함을 특징으로한다.Extract according to the present invention is characterized in that it is contained in an amount of 0.001 to 50% by weight, preferably 0.01 to 5% by weight relative to the dry weight of the cosmetics attached.

0.001중량% 이하로 함유되면, 본 발명에 따른 추출물의 작용효과인 티로시나제 저해활성이 거의 나타나지 않으며, 50중량%를 초과하면 화장료의 안정성에 불리 할 뿐 아니라 과잉 부가에 따른 작용효과의 상승효과도 나타나지 않아 바람직하지 못하다.If it is contained in an amount of 0.001% by weight or less, tyrosinase inhibitory activity, which is an action effect of the extract according to the present invention, is hardly exhibited, and when it exceeds 50% by weight, it is not only detrimental to the stability of the cosmetics, but also shows a synergistic effect of the effect of excess addition. Not desirable.

한편, 본 발명에 따른 화장료 조성물은 상기한 추출물 외에 본 발명이 목적으로 하는 주 효과를 상승 혹은 보조할 수 있는 다른 성분들을 함유할 수 도 있음은 물론이며, 예를 들어 이러한 보조 성분으로서 종래에 미백 작용이 있는 것으로 알려진 코진산, 알부틴, 아스코르브산 유도체 등을 들 수 있다.On the other hand, the cosmetic composition according to the present invention may contain other ingredients that can enhance or aid the main effect of the present invention in addition to the above-described extract, of course, for example whitening conventionally as such an auxiliary ingredient Kojic acid, arbutin, ascorbic acid derivatives and the like which are known to have an action.

상술한 바와 같이 본 발명에 따른 추출물을 구성하는 조성물 각각에 대한 특성은 아래와 같다.As described above, the characteristics of each of the compositions constituting the extract according to the present invention are as follows.

맬로우(Mallow)는 '부드러운' 또는 '안정시키는'이란 뜻을 지닌 그리스어 "malakos"에서 유래하여 Malva Sylvestris로 불리워지며, 6월에서 9월 사이에 옅은 적색 혹은 보라색 꽃을 피우고 주로 이용되는 부위는 잎과 꽃이다. 점액질과 탄닌성분이 풍부하여 기관지염, 기침을 완화해 주는 작용과 위염에도 효과적인 것으로 알려져 있다.Mallow is called Malva Sylvestris , derived from the Greek word "malakos" which means "soft" or "stabilizing", and the areas that are mostly used are pale red or purple flowers between June and September. It is a leaf and a flower. Rich in mucus and tannins, it is known to be effective in relieving bronchitis and cough and gastritis.

서양앵초(Primula Veris)는 다년생 초본식물인 앵초로써 유럽사회에서는 오래 전부터 약용으로 이용되고 있다. 우리나라에서도 진해, 거담, 해소, 기관지염등에 사용되고 있으며 다량의 싸포닌을 포함하고 있다. Primula Veris is a perennial herbaceous primrose, which has been used for a long time in Europe. It is used in Jinhae, expectorant, relieving, bronchitis in Korea and contains a large amount of saponin.

박하(Menthe Herba)는 순형(脣形, Labiatae)과 식물로서 진통, 방부, 수렴작용 및 순환계통 강화에 효과가 있다. 특히 피부의 모세혈관을 확장하는 효과가 있다. 주성분으로는 멘톨로 약 77~78%를 함유하며 멘톤(menthone), 멘톨(menthol), 캠펜(camphene), 리모넨(limonene), 이소멘톤(isomenthone), 피넨(pinene) 등의 성 분이 존재한다. 또한, 탄닌 및 트리터펜(Triterpene)과 메칠화된 여러가지 형태의 플라보노이드(Flavonoid) 성분들이 존재한다.Peppermint ( Menthe Herba ) is a labiatae and a plant that is effective in analgesic, antiseptic, astringent and circulatory system strengthening. In particular, it has the effect of expanding the capillaries of the skin. The main ingredient is menthol, which contains about 77% to 78%, and there are menthol (menthone), menthol (menthol), camphene (limonene), isomentone (isomenthone) and pinene (pinene). In addition, there are various forms of flavonoids that have been tanned with methylnin and triterpene.

성모초(Alchemilla Vulgaris)는 '연금술'을 의미하는 아랍어 alkemelych에서 유래되었다. 성모초는 예전부터 부인성 질환을 치료하는데 사용되어 왔으며 잎의 경우 화장품원료로 사용되기도 하였다. 특히, 잎에 칼로탄닌(Gallotannin) 및 플라보노이드 성분들이 존재하는 것으로 알려져 있다.Our Lady of Alchemilla Vulgaris is derived from the Arabic alkemelych, meaning 'alchemy'. St. Mary's has been used to treat gynecological diseases for a long time, and leaf has been used as a cosmetic ingredient. In particular, it is known that calotannin and flavonoid components are present in the leaves.

꼬리풀은 현삼과(Scrophulariaceae) 여러해살이풀로 우리나라에도 널리 분포한다. 한약명으로는 세엽파파납(細葉婆婆納)이라고도 불리우며 농혈을 치료하는데 효과가 있다. 탄닌 성분과 플라보노이드성분들이 다량 존재한다.Kkoripul is widely distributed in Korea in Scrophulariaceae (Scrophulariaceae) perennial plant. In the name of Chinese medicine, it is also called cefolipapa nap (細葉 婆婆 納), and is effective in treating emphysema. Tannins and flavonoids are present in large quantities.

메릿사(Melissa officinalis)는 꿀풀과의 다년생초본으로 유럽에서는 약초로 알려져 있다. 진정작용, 신경계을 통한 혈압하강작용, 심장강화작용 등이 알려져 있다. 약 70여가지의 터펜(Terpene)류들로 구성된 에션셜오일들이 0.02~0.3% 포함되어 있다. Melissa officinalis is a perennial herb of Lamiaceae and is known in Europe as a herb. Sedation, blood pressure lowering through the nervous system, heart strengthening is known. Essential oils, composed of about 70 terpenes, contain 0.02-0.3%.

야로우(Yarrow)는 국화과의 다년생초본으로 유럽에서는 학명 아칠리 밀레폴리윰(Achillea Millefolium)으로 알려져 있다. 학명은 일리아드의 영웅 '아킬레스'가 트로이전쟁 때 부상한 병사들을 이 풀로 치료한데서 기인되었다. 지혈작용, 소독작용, 강장효과 등이 알려져 있다.Yarrow is a perennial herb from the Asteraceae family and is known in Europe as the scientific name Achillea Millefolium . The scientific name stems from the Iliad hero Achilles' treatment of the wounded soldiers in the Trojan War. Hemostatic action, disinfection, tonic effect is known.

상기와 같이 구성되는 본 발명은 본 발명의 추출물을 구성하는 각 식물들이 상기한 바와 같이 다량의 탄닌, 플라보노이드 성분을 함유하여 이들 활성성분을 추출하여 조성물로 함으로서 미백효과가 부여될 수 있을 뿐 아니라 이들 추출물을 일 정비율로 구성하여 화장료 조성물로 함으로서 티로시나제의 억제 활성과 안전성이 우수한 화장료 조성물을 제공할 수 있다.The present invention constituted as described above can be given not only a whitening effect by extracting these active ingredients into the composition of each plant constituting the extract of the present invention containing a large amount of tannin, flavonoid components as described above By constructing the extract at a maintenance rate as a cosmetic composition, it is possible to provide a cosmetic composition excellent in inhibitory activity and safety of tyrosinase.

또한, 본 발명의 구성인 효모추출물의 효모는 유전자시스템이 잘 공지되어있으며, 어떤 종류의 미생물 보다 간단한 발효조건에 의해서 폴리펩타이드생산에 유리한 것으로 알려져 있다. 효모는 유산균인 락토코커스(Lactococcus), 스트렙토코커스(Streptococcus)등과 함께 미백, 보습, 피부소프닝등에 사용되고 있다. In addition, the yeast extract of the yeast extract which is a constituent of the present invention is well known in the genetic system, it is known to be advantageous for polypeptide production by simple fermentation conditions than any kind of microorganism. Yeast is used for whitening, moisturizing and skin softening along with Lactococcus and Streptococcus.

이하, 본 발명을 실시예로 보다 자세히 설명하지만, 본 발명이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.

실시예 1Example 1

맬로우, 서양앵초, 성모초, 꼬리풀, 야로우의 꽃과 잎을 정제수로 세척하고 건조시킨 다음 분말화하였다. 박하, 메릿사의 경우에는 잎만을 분말화하였다. 분말화 된 식물혼합물을 85% 저급 알코올로 1일간 저온 숙성 시킨후 2시간 동안 초고주파처리하여 상층액을 1차 여과 후 남은 잔여물에 85% 저급 알코올로 2시간 동안 초고주파처리하고 층액을 여과하는 과정을 두 번 더 반복하였다. 50℃ 이하에서 감압 농축하여 분말상의 식물추출물을 얻었으며, 이를 효모추출물과 1:1로 혼합하여 본 발명의 추출물을 얻었다.The flowers and leaves of the mallow, primrose, virginia, tail grass and yarrow were washed with purified water, dried and then powdered. In the case of mint and Meritz, only leaves were powdered. Process of pulverizing the powdered plant mixture with 85% lower alcohol for 1 day and then ultra-high frequency treatment for 2 hours, ultra-high frequency treatment of the supernatant with 85% lower alcohol for 2 hours, and filtering the layer solution Was repeated two more times. Concentrated under reduced pressure at 50 ℃ or less to obtain a powdery plant extract, which was mixed 1: 1 with yeast extract to obtain the extract of the present invention.

실시예2-8Example 2-8

본 발명의 추출물을 구성하는 각각의 식물을 대상으로하는 외에는 상기 실시예 1과 같은 방법으로 추출을 실시하여 아래 표 1과 같은 최종 수율로 각각의 추출물을 얻었다. Except for each plant constituting the extract of the present invention was extracted in the same manner as in Example 1 to obtain each extract in the final yield as shown in Table 1 below.                     

식물명Botanical name 수율(%)yield(%) 실시예 2Example 2 맬로우Mallow 6.56.5 실시예 3Example 3 서양앵초Primrose 10.210.2 실시예 4Example 4 성모초Our Lady 7.97.9 실시예 5Example 5 꼬리풀Tail grass 24.424.4 실시예 6Example 6 야로우Yarrow 8.48.4 실시예 7Example 7 박하mint 13.413.4 실시예 8Example 8 메릿사Meritz 16.216.2

실험예 1 : 티로시나제(Tyrosinase) 활성 억제 실험 Experimental Example 1 : Tyrosinase activity inhibition experiment

상기 실시예 1~8에 따라 수득된 추출물을 각 농도별로 에탄올에 희석하였다. 96-웰 마이크로플레이트(96-well microplate)에 1.5mM L-티로신 5㎕, 25mM L-DOPA 40㎕를 첨가한 후, 10, 100, 500, 1000㎕/㎖의 농도 시료를 40㎕씩 첨가하였다. 67 mM 인산염 완충액(pH 6.8) 80㎕를 첨가하여 시료와의 총부피 합이 165㎕가 되게 하였다. 블랭크에는 80㎕의 완충액을 넣고 나머지 검색용 시료용액에는 80㎕의 머쉬룸(mushroom) 티로시나제(60 U/㎖)를 첨가한 후 37℃에서 30분간 배양하였다. ELISA 리더(reader)를 이용하여 생성된 도파 크롬(dopa chrome)의 양을 490㎚에서 흡광도를 측정한 후 그 저해율은 다음과 같이 계산하였다.
The extracts obtained according to Examples 1 to 8 were diluted in ethanol at each concentration. 5 µl of 1.5 mM L-tyrosine and 40 µl of 25 mM L-DOPA were added to a 96-well microplate, followed by 40 µl of 10, 100, 500, 1000 µl / ml samples. . 80 μl of 67 mM phosphate buffer (pH 6.8) was added to bring the total volume with the sample to 165 μl. 80 μl of buffer was added to the blank, and 80 μl of mushroom tyrosinase (60 U / ml) was added to the remaining sample solution, followed by incubation at 37 ° C. for 30 minutes. The amount of dopa chrome produced using an ELISA reader was measured for absorbance at 490 nm, and the inhibition rate was calculated as follows.

저해율=[(대조군의 A490-시료용액이 첨가된 것의 A490)/대조군의 A490]×100
Inhibition rate = [(A490 of the control A490-sample solution added) / control A490] × 100

양성 대조군으로 코진산을 사용하였으며, 상기 방법으로 부터, 각 실시예에 따라 수득된 추출물의 티로시나제 활성 저해율을 측정하여 하기 표 2에 나타내었다. Kozinic acid was used as a positive control, and from the above method, the tyrosinase activity inhibition rate of the extract obtained according to each example was measured and shown in Table 2 below.                     

사용농도(㎕/㎖)Concentration (μl / ml) 저해율(%)% Inhibition 실시예 2Example 2 1010 2.22.2 실시예 3Example 3 1010 4.04.0 실시예 4Example 4 1010 1.01.0 실시예 5Example 5 1010 1.91.9 실시예 6Example 6 1010 3.03.0 실시예 7Example 7 1010 4.94.9 실시예 8Example 8 1010 3.93.9 실시예 1Example 1 1010 9.49.4 대조군(코진산)Control group (kozinic acid) 1010 1.91.9

표 2에서 보는 바와 같이 본 발명에 의한 실시예 1~8은 10㎕/㎖의 낮은 농도에서 매우 높은 멜라닌 생성 저해효과를 나타내었다. 또한 각각의 추출물의 효과보다는 혼합물인 실시예 1이 경우 미백효과가 우수함을 알 수 있다.As shown in Table 2, Examples 1 to 8 according to the present invention showed very high melanin production inhibitory effect at a low concentration of 10 μl / ml. In addition, it can be seen that in Example 1 which is a mixture rather than the effect of each extract, the whitening effect is excellent.

실험예 2 : 세포독성 및 세포내 멜라닌 생성 억제 실험 Experimental Example 2 Cytotoxicity and Inhibition of Intracellular Melanin Production

B16 마우스 멜라노마(mouse melanoma) 세포를 10% FBS가 포함된 DMEM 배지 조건에서 배양 한 후 1×104 세포/24웰의 농도로 세포주를 접종하였다. 37℃, 5% CO2 환경에서 24시간 배양 후 매일 웰당 1000㎕의 신선한 배지로 갈아주면서 실시예 1 에서 수득한 추출물을 1, 10, 100㎕/㎖ 농도별로 10㎕씩 3일간 처리한 후 1일간 더 배양하였다. 세포 증식의 측정은 디메틸아졸-디페닐테트라졸륨 브로마이드(MTT) 환원법을 이용하여 세포 농도를 측정한 후, 계산하였다.B16 mouse melanoma cells (mouse melanoma) cells were incubated in DMEM medium conditions containing 10% FBS and inoculated with cell lines at a concentration of 1 × 10 4 cells / 24 wells. After 24 hours of incubation at 37 ° C. in a 5% CO 2 environment, the extract obtained in Example 1 was treated with 10 μl of 1, 10, 100 μl / ml concentration for 3 days after changing to 1000 μl of fresh medium per well every day. Incubated for more days. The measurement of cell proliferation was calculated after measuring the cell concentration using the dimethylazole-diphenyltetrazolium bromide (MTT) reduction method.

[수학식 1][Equation 1]

대조군의 세포증식 시간         Cell proliferation time of control group

* 세포증식률 = ----------------------- ×100* Cell growth rate = ----------------------- × 100

실험군의 세포증식 시간          Cell growth time of the experimental group                     

시료의 종류Type of sample 세포증식률(%)Cell growth rate (%) 대조군Control 100100 1㎕/㎖1 μl / ml 99±0.599 ± 0.5 10㎕/㎖10 μl / ml 99.2±0.499.2 ± 0.4 100㎕/㎖100 μl / ml 98.9±0.798.9 ± 0.7

상기와 같은 실험을 실시한 결과, 실시예 1 에 따른 본 발명의 구성은 세포생존율에 영향을 주지 않았으므로 세포 독성이 없다는 것을 알 수 있었다.As a result of the above experiment, it was found that the composition of the present invention according to Example 1 was not cytotoxic because it did not affect the cell viability.

제조예 1Preparation Example 1

상기 실시예 1에 따른 추출물을 함유하는 유연화장수의 제조예는 다음 표 3과 같다.Preparation Example of the flexible longevity containing the extract according to Example 1 is shown in Table 3.

성분ingredient 함량(중량%)Content (% by weight) 살리실산Salicylic acid 0.50.5 1,3-부틸렌글리콜1,3-butylene glycol 5.05.0 모노라우린산 폴리옥시에틸렌소르비탄Monolauric acid polyoxyethylene sorbitan 1.31.3 폴리옥시에틸렌 라우릴에테르Polyoxyethylene lauryl ether 0.70.7 에탄올ethanol 15.015.0 향료Spices 0.20.2 방부제antiseptic 적량Quantity 실시예 1의 추출물Extract of Example 1 0.050.05 정제수Purified water 잔부Remainder

제조예 2Production Example 2

상기 실시예 1에 따른 추출물을 함유하는 로션의 제조예는 다음 표 4와 같다. Preparation of the lotion containing the extract according to Example 1 is shown in Table 4.                     

성분ingredient 함량(중량%)Content (% by weight) 스테아린산Stearic acid 0.50.5 에탄올ethanol 10.010.0 바세린Vaseline 1.01.0 스쿠알란Squalane 2.52.5 유동파라핀Liquid paraffin 6.06.0 모노올레인산 폴리옥시에틸렌소르비탄Monooleic acid polyoxyethylene sorbitan 1.51.5 1,3-부틸렌글리콜1,3-butylene glycol 8.08.0 에틸렌디아민테트라아세트산 나트륨Ethylenediaminetetraacetic acid sodium 0.050.05 트리에탄올 아민Triethanol amine 0.80.8 향료Spices 0.20.2 방부제antiseptic 적량Quantity 산화 방지제Antioxidant 적량Quantity 실시예 1의 추출물Extract of Example 1 0.050.05 정제수Purified water 잔부Remainder

제조예 3Production Example 3

상기 실시예 1에 따른 추출물을 함유하는 에센스의 제조예는 다음 표 5와 같다.Preparation of the essence containing the extract according to Example 1 is shown in Table 5.

성분ingredient 함량(중량%)Content (% by weight) 글리세린glycerin 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 5.05.0 세스퀴올레인산소르비탄Sesquioleate sorbitan 0.40.4 폴리라우린산 폴리옥시에틸렌소르비탄Polylauric acid polyoxyethylene sorbitan 1.01.0 파라옥시안식향산 메칠Paraoxybenzoic Acid Methyl 0.20.2 에탄올ethanol 2.02.0 정제수Purified water 잔부Remainder 바세린Vaseline 5.05.0 세탄올Cetanol 0.20.2 실시예 1의 추출물Extract of Example 1 0.50.5

제조예 4Preparation Example 4

상기 실시예 1에 따른 추출물을 함유하는 크림의 제조예는 다음 표 6와 같다. Preparation of the cream containing the extract according to Example 1 is shown in Table 6.                     

성분ingredient 함량(중량%)Content (% by weight) 스테아린산Stearic acid 0.50.5 에탄올ethanol 10.010.0 바세린Vaseline 1.01.0 스쿠알란Squalane 2.52.5 유동파라핀Liquid paraffin 6.06.0 모노올레인산 폴리옥시에틸렌소르비탄Monooleic acid polyoxyethylene sorbitan 1.51.5 1,3-부틸렌글리콜1,3-butylene glycol 8.08.0 에틸렌디아민테트라아세트산 나트륨Ethylenediaminetetraacetic acid sodium 0.050.05 트리에탄올 아민Triethanol amine 0.80.8 향료Spices 0.20.2 방부제antiseptic 적량Quantity 산화 방지제Antioxidant 적량Quantity 실시예 1의 추출물Extract of Example 1 0.050.05 정제수Purified water 잔부Remainder

비교예 1 : 로션Comparative Example 1: Lotion

성분ingredient 함량(중량%)Content (% by weight) 스테아린산Stearic acid 0.50.5 에탄올ethanol 10.010.0 바세린Vaseline 1.01.0 스쿠알란Squalane 2.52.5 유동파라핀Liquid paraffin 6.06.0 모노올레인산 폴리옥시에틸렌소르비탄Monooleic acid polyoxyethylene sorbitan 1.51.5 1,3-부틸렌글리콜1,3-butylene glycol 8.08.0 에틸렌디아민테트라아세트산 나트륨Ethylenediaminetetraacetic acid sodium 0.050.05 트리에탄올 아민Triethanol amine 0.80.8 향료Spices 0.20.2 방부제antiseptic 적량Quantity 산화 방지제Antioxidant 적량Quantity 정제수Purified water 잔부Remainder

비교예 2 : 에센스Comparative Example 2: Essence

성분ingredient 함량(중량%)Content (% by weight) 글리세린glycerin 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 5.05.0 세스퀴올레인산소르비탄Sesquioleate sorbitan 0.40.4 폴리라우린산 폴리옥시에틸렌소르비탄Polylauric acid polyoxyethylene sorbitan 1.01.0 파라옥시안식향산 메칠Paraoxybenzoic Acid Methyl 0.20.2 에탄올ethanol 2.02.0 바세린Vaseline 5.05.0 세탄올Cetanol 0.20.2 정제수Purified water 잔부Remainder

비교예 3 : 크림Comparative Example 3: Cream

성분ingredient 함량(중량%)Content (% by weight) 스테아린산Stearic acid 0.50.5 에탄올ethanol 10.010.0 바세린Vaseline 1.01.0 스쿠알란Squalane 2.52.5 유동파라핀Liquid paraffin 6.06.0 모노올레인산 폴리옥시에틸렌소르비탄Monooleic acid polyoxyethylene sorbitan 1.51.5 1,3-부틸렌글리콜1,3-butylene glycol 8.08.0 에틸렌디아민테트라아세트산 나트륨Ethylenediaminetetraacetic acid sodium 0.050.05 트리에탄올 아민Triethanol amine 0.80.8 향료Spices 0.20.2 방부제antiseptic 적량Quantity 산화 방지제Antioxidant 적량Quantity 정제수Purified water 잔부Remainder

실험예 3 : 피부안전성 시험Experimental Example 3: Skin Safety Test

상기 제조예 1~4 및 비교예 1~3에서 통상적인 방법에 따라 제조한 제품들의 피부자극성을 알아보기 위하여, 건강한 성인남녀 30명을 대상으로 팔하박부에 각 시료의 적당량(2.0g)을 첩포시험용 헤이즐챔버에 묻혀 48시간 첩포한 후, 헤이즐챔버를 제거하고 30분∼1시간 경과후 육안으로 피부상태 변화를 판독하여 이를 1차판 정한 다음 제거하고 48시간 이후에 다시 판독하여 이를 2차 판정으로 하였으며, 그 결과를 하기의 표 11에 나타낸다.In order to examine the skin irritation properties of the products prepared according to the conventional methods in Preparation Examples 1 to 4 and Comparative Examples 1 to 3, an appropriate amount (2.0 g) of each sample was applied to the lower arm and hip for 30 healthy adult men and women. Buried in a test hazel chamber for 48 hours, the hazel chamber was removed, and after 30 minutes to 1 hour, the skin condition was visually read and the first plate was determined and then removed. After 48 hours, it was read again as a second judgment. The results are shown in Table 11 below.

자극도Stimulus 제품product 피시험자수Number of test subjects 판정결과Judgment result 자극도Stimulus -- ±± ++ ++++ ++++++ 1차Primary 2차Secondary 1차Primary 2차Secondary 1차Primary 2차Secondary 1차Primary 2차Secondary 1차Primary 2차Secondary 제조예1Preparation Example 1 3030 2929 3030 0.270.27 제조예2Preparation Example 2 3030 3030 3030 00 제조예3Preparation Example 3 3030 2929 3030 0.270.27 제조예4Production Example 4 3030 3030 3030 00 비교예1Comparative Example 1 3030 3030 3030 00 비교예2Comparative Example 2 3030 3030 3030 00 비교예3Comparative Example 3 3030 2929 3030 0.270.27

* 판정표* Judgment Table

- : 반응없슴 (자극 정도 :0)  -: No reaction (Irritation level: 0)

±: 의심되는 양성반응. 약간의 홍반반응 있슴. (자극 정도 :0.5)  ± suspected positive reaction. Slight erythema reactions. (Irritation degree: 0.5)

+: 약간의 양성반응. 홍반, 구진, 확실한 인설반응 (자극 정도 :1.0)  +: Slight positive reaction. Erythema, papules, positive pullback reaction (irritation degree: 1.0)

++: 심한 양성반응. 소포성 반응: 홍반, 구진, 침윤병소, 소포 (자극 정도 :2.0)  ++: Severe positive reaction. Vesicular reactions: erythema, papules, infiltrating lesions, vesicles (irritation degree: 2.0)

+++: 격심한 양성반응. (자극 정도 :3.0)  +++: Severe positive reaction. (Irritation degree: 3.0)

[수학식 2][Equation 2]

(±반응자수x0.5)+(+반응자수x1)+(++반응자수x2)+(+++반응자수x3)         (± responders x 0.5) + (+ responders x 1) + (++ responders x 2) + (+++ responders x 3)

*자극도 = ---------------------------------------------------------- x100x1/2* Stimulus = ---------------------------------------------- ------------ x100x1 / 2

총시험자수 x 최대반응정도 (3)                       Total number of investigators x response rate (3)                     

상기한 피부자극성 시험 결과로부터, 실시예들의 제품에 있어 자극성은 거의 인정되지 않았다.
From the skin irritation test results described above, irritation was hardly recognized in the products of the examples.

실험예 4 : 멜라닌지수의 측정 Experimental Example 4 Measurement of Melanin Index

제조예 1 내지 4에 따라 제조된 화장료를 적용한 후, 멜라닌-에리데마 인덱스 메터(melanin-erythema index meter)로 멜라닌지수를 측정하여 표 12에 나타냈다.After applying the cosmetics prepared according to Preparation Examples 1 to 4, the melanin index was measured by using a melanin-erythema index meter and shown in Table 12.

멜라닌지수Melanin index 사용전Before use 사용후after use 실험군Experimental group 110.35±30.41110.35 ± 30.41 93.40±31.4593.40 ± 31.45 대조군Control 102.47±23.49102.47 ± 23.49 111.83±33.03111.83 ± 33.03

상기의 결과로부터 제조예 1 내지 4에 따른 화장료를 사용한 실험군은 대조군에 비해 멜라닌지수를 감소시켰음을 나타낸다. 따라서, 본 발명에 따른 실시에 1의 추출물을 함유한 화장료는 미백효과가 있음을 알 수 있다.
From the above results, the experimental group using the cosmetics according to Preparation Examples 1 to 4 shows that the melanin index was reduced compared to the control group. Therefore, it can be seen that the cosmetic composition containing the extract of Example 1 according to the present invention has a whitening effect.

실험예 5 : 안정성 실험 Experimental Example 5 : Stability Experiment

본 발명에 따른 화장료의 안정성을 시험하기 위해 제조예 1 내지 4에 따라 제조된 화장료를 상온과 일정한 온도가 유지되는 5℃, 37℃, 43℃, 50℃ 항온조와 -5℃에서 50℃를 단계적으로 순환하는 항온조에서 일정기간 보관하여 분리 정도 및 변색 정도를 비교 측정하였다. 그 결과 아래 표 13에 나타내었다. 이때 제품 분리 및 변색 정도를 다음의 4등급으로 분류하여 평가하였다.In order to test the stability of the cosmetics according to the present invention, the cosmetics prepared according to Preparation Examples 1 to 4 were subjected to stepwise 5 ° C, 37 ° C, 43 ° C, 50 ° C and 50 ° C at -5 ° C to maintain a constant temperature at room temperature. The degree of dissociation and the degree of discoloration were measured by storing in a constant temperature bath for a period of time. The results are shown in Table 13 below. At this time, the degree of product separation and discoloration were evaluated by classifying into the following four grades.

* 제품 분리 및 변색 평가 기준* Standards for product separation and discoloration

0 : 변화 없음 1 : 조금 분리(변색)0: No change 1: Separated slightly (discoloration)

2 : 심하게 분리(변색) 3 : 극히 심하게 분리(변색) 2: severely separated (discolored) 3: extremely severely separated (discolored)

온 도Temperature 기간 (개월)Duration (months) 분리 및 변색정도Separation and discoloration 제조예 1Preparation Example 1 제조예 2Production Example 2 제조예 3Production Example 3 제조예 4Preparation Example 4 5℃5 ℃ 1One 00 00 00 00 상온Room temperature 66 00 00 00 00 37℃37 ℃ 33 00 00 00 00 43℃43 ℃ 22 00 00 00 00 50℃50 ℃ 1One 00 00 00 00 -5℃~50℃-5 ℃ ~ 50 ℃ 1One 00 00 00 00

상기 표 13에서 알 수 있는 바와 같이, 제조예 1 내지 4에 따라 제조된 화장료는 분리 및 변색되지 않아 안정하다는 것을 알 수 있다.As can be seen in Table 13, it can be seen that the cosmetics prepared according to Preparation Examples 1 to 4 are not separated and discolored and are stable.

상술한 바와 같이 본 발명의 추출물은 함유하는 화장료는 추출물의 각 구성성분이 천연추출물과 미생물 발효물로 피부안전성이 높을 뿐만 아니라, 더욱이 본 발명에 따른 추출물은 제품의 안정성에 영향을 미치지 않는 농도에서 피부색개선 효과가 있고 색소침착을 감소시키는 효과가 있어 피부개선 및 미백화장료에 유효농도로 사용할 수 있다.As described above, the cosmetic composition containing the extract of the present invention is not only high in skin safety as each component of the extract is a natural extract and a microbial fermentation, but moreover, the extract according to the present invention has a concentration that does not affect the stability of the product. It has the effect of improving skin color and reduces pigmentation, so it can be used at effective concentration in skin improvement and whitening cosmetics.

Claims (3)

맬로우(Malva Sylvestris), 서양앵초(Primula Veris), 성모초(Alchemilla Vulgaris), 꼬리풀, 야로우(Achillea Millefolium) 식물의 꽃과 잎을 물 또는 유기용매를 사용하여 추출한 추출물; Extracts from flowers and leaves of Malva Sylvestris , Primula Veris , Alchemilla Vulgaris , tail grass , Yarrow ( Achillea Millefolium ) plants using water or organic solvents; 박하(Menthe Herba), 메릿사(Melissa officinalis) 잎을 물 또는 유기용매를 사용하여 추출한 추출물; 및 Extract extracted from the leaves of Menthe Herba and Melissa officinalis using water or an organic solvent; And 효모 추출물을 포함하는 것을 특징으로 하는 식물 추출물을 함유한 피부 미백 화장료.Skin whitening cosmetics containing a plant extract, characterized in that it comprises a yeast extract. 제1항에 있어서, The method of claim 1, 상기 미백 화장료에 포함되는 모든 추출물의 총 함량이 상기 미백 화장료의 건조중량에 대하여 0.01∼5 중량%인 것을 특징으로 하는 식물 추출물을 함유한 피부 미백 화장료.Skin whitening cosmetics containing a plant extract, characterized in that the total content of all the extracts contained in the whitening cosmetics is 0.01 to 5% by weight relative to the dry weight of the whitening cosmetics. 제1항 또는 제2항에 있어서,  The method according to claim 1 or 2, 상기 미백 화장료의 제형이 유연 화장수, 로션, 에센스, 크림에서 선택된 어느 하나임을 특징으로 하는 식물 추출물을 함유한 피부 미백 화장료.Skin whitening cosmetics containing a plant extract, characterized in that the formulation of the whitening cosmetic is any one selected from flexible lotion, lotion, essence, cream.
KR1020030022179A 2003-04-09 2003-04-09 Cosmetic composition comprising a herbal extration KR100967018B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030022179A KR100967018B1 (en) 2003-04-09 2003-04-09 Cosmetic composition comprising a herbal extration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030022179A KR100967018B1 (en) 2003-04-09 2003-04-09 Cosmetic composition comprising a herbal extration

Publications (2)

Publication Number Publication Date
KR20040087777A KR20040087777A (en) 2004-10-15
KR100967018B1 true KR100967018B1 (en) 2010-06-30

Family

ID=37369871

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030022179A KR100967018B1 (en) 2003-04-09 2003-04-09 Cosmetic composition comprising a herbal extration

Country Status (1)

Country Link
KR (1) KR100967018B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101214944B1 (en) 2006-03-03 2012-12-24 (주)아모레퍼시픽 Cosmetic composition containing Sacchromyces polypeptides and β-1,3-glucane for moisturizing effect on the skin
KR101326556B1 (en) * 2013-08-02 2013-11-07 주식회사 더마랩 Cosmetic composition for ultraviolet-proof containing the extract of sanguisorba officinalis and v. linariaefolia
KR101542490B1 (en) 2011-12-12 2015-08-07 양정님 Cosmetic composition comprising the mixed extracts of Achillea, Borage, Helichrysum, Lady's mantle, and Eucalyptus
KR20200021258A (en) 2018-08-20 2020-02-28 주식회사 코씨드바이오팜 Cosmetic composition for scalp improvement with the extract of cowslip
KR102367436B1 (en) 2021-04-22 2022-02-25 (주)인터케어 Composition comprising mixed fermented product of young trifoliate orange, young green tea and bitter orange flower, and its use for improving skin condition

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2903902B1 (en) * 2006-07-21 2013-02-15 Clarins Lab USE OF A COSMETIC COMPOSITION TO PROMOTE SKIN DEPIGMENTATION.
KR101282335B1 (en) * 2010-01-29 2013-07-05 고려대학교 산학협력단 Compositions comprising an extract of lemon balm for skin-whitening effect
US20150024072A1 (en) * 2013-07-22 2015-01-22 Johnson & Johnson Consumer Companies, Inc. Methods of treating a skin condition with malva neglecta

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033007A1 (en) 2001-10-17 2003-04-24 Mario Baraldi Pharmaceutical compositions for the topical use containing medicinal plants extracts with antiphlogistic and cicatrising activities
KR20030074707A (en) * 2001-02-16 2003-09-19 펜타팜아게 Cosmetically effective composition containing malva sylvestris and mentha piperita extracts
JP2003342122A (en) 2002-05-30 2003-12-03 Noevir Co Ltd Skin care preparation
KR20040046507A (en) * 2002-11-27 2004-06-05 나드리화장품주식회사 Cosmetic composition containing ceramide liposome with phyto complex extract and ceramide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030074707A (en) * 2001-02-16 2003-09-19 펜타팜아게 Cosmetically effective composition containing malva sylvestris and mentha piperita extracts
WO2003033007A1 (en) 2001-10-17 2003-04-24 Mario Baraldi Pharmaceutical compositions for the topical use containing medicinal plants extracts with antiphlogistic and cicatrising activities
JP2003342122A (en) 2002-05-30 2003-12-03 Noevir Co Ltd Skin care preparation
KR20040046507A (en) * 2002-11-27 2004-06-05 나드리화장품주식회사 Cosmetic composition containing ceramide liposome with phyto complex extract and ceramide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101214944B1 (en) 2006-03-03 2012-12-24 (주)아모레퍼시픽 Cosmetic composition containing Sacchromyces polypeptides and β-1,3-glucane for moisturizing effect on the skin
KR101542490B1 (en) 2011-12-12 2015-08-07 양정님 Cosmetic composition comprising the mixed extracts of Achillea, Borage, Helichrysum, Lady's mantle, and Eucalyptus
KR101326556B1 (en) * 2013-08-02 2013-11-07 주식회사 더마랩 Cosmetic composition for ultraviolet-proof containing the extract of sanguisorba officinalis and v. linariaefolia
KR20200021258A (en) 2018-08-20 2020-02-28 주식회사 코씨드바이오팜 Cosmetic composition for scalp improvement with the extract of cowslip
KR102367436B1 (en) 2021-04-22 2022-02-25 (주)인터케어 Composition comprising mixed fermented product of young trifoliate orange, young green tea and bitter orange flower, and its use for improving skin condition

Also Published As

Publication number Publication date
KR20040087777A (en) 2004-10-15

Similar Documents

Publication Publication Date Title
KR100964723B1 (en) Cosmetic composition containing wild flower extracts
KR101873028B1 (en) Cosmetic composition containing complex extract of herbs
KR20090055309A (en) A cosmetic composition for skin whitening and treating wrinkles
KR101824770B1 (en) Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract
JPH06227960A (en) Melanin formation inhibitor and skin cosmetic
KR100967018B1 (en) Cosmetic composition comprising a herbal extration
KR100710657B1 (en) Whitening cosmetic composition containing dihydroquercetin
KR20220112447A (en) Composition for improving skin, comprising Elaeaqnus macrophylla Extract as effective components, Cosmetic composition and Food functional composition including the same
KR100350083B1 (en) Compositions for whitening cosmetics
KR20020035656A (en) Inhibition agent of tyrosinase composed of saururus chinensis(lour) baill extract and cosmetic composition having whitening effect containing the same
KR101456059B1 (en) The cosmetic composition effective in whitening and anti-aging mainly comprised of roasted licorice extract
KR100789632B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20050092313A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR101214347B1 (en) Method for Extracting Herbal Ingredient
KR100789634B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR101686521B1 (en) Composition for beauty of skin
KR100829718B1 (en) Cosmetic Composition for Whitening the Skin Comprising the Extract of Ilex rotunda as Active Ingredient
KR20120118946A (en) Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts
KR20030090188A (en) Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening
KR101176525B1 (en) Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient
KR20040076103A (en) Method of producing a cosmetic composition which contains mixed plant extracts
KR20050092314A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR20150106111A (en) Composition for preventing or treating ultravilet-induced skin damage
KR101521579B1 (en) Skin Whitening and Anti―oxidative Composition Containing Boesenbergia rotunda Extract
KR102374994B1 (en) Cosmetic Compositions Having Extracts of JEJU Lava Seawater and JEJU Sasa querlpaertensis Nakai and Preparation Methods Using Thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130610

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140617

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150610

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160608

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20170612

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20190610

Year of fee payment: 10